Boothbay Fund Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boothbay Fund Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.84M	Buy	11,616 +2,692	+30%	+$364K	0.02%	767
2026 Q1	$1.14M	Buy	+8,924	New	+$1.11M	0.01%	882
2024 Q4	–	Sell	-8,970	Closed	-$869K	–	1950
2024 Q3	$886K	Buy	8,970 +3,945	+79%	+$388K	0.02%	792
2024 Q2	$466K	Buy	+5,025	New	+$451K	0.01%	1011
2023 Q3	–	Sell	-10,873	Closed	-$869K	–	2119
2023 Q2	$905K	Buy	+10,873	New	+$909K	0.02%	874
2022 Q1	–	Sell	-2,285	Closed	-$211K	–	2574
2021 Q4	$256K	Sell	2,285 -862	-27%	-$104K	0.01%	1339
2021 Q3	$396K	Buy	+3,147	New	+$405K	0.01%	1202
2018 Q4	–	Sell	-12,500	Closed	-$1.2M	–	923
2018 Q3	$1.2M	Buy	+12,500	New	+$1.21M	0.12%	166
2017 Q2	–	Sell	-7,400	Closed	-$513K	–	868
2017 Q1	$513K	Buy	+7,400	New	+$497K	0.1%	252

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Boothbay Fund Management's XBI Position: Q2 2026 in Review

Boothbay Fund Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 30% in Q2 2026, buying an estimated $364K and bringing the position to 11,616 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #767.

Boothbay Fund Management first reported a position in XBI in Q1 2017 and has held it in 9 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Boothbay Fund Management held 11,616 shares of State Street SPDR S&P Biotech ETF worth $1.84M as of Q2 2026.
Boothbay Fund Management bought 2,692 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $364K.
State Street SPDR S&P Biotech ETF made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #767 holding.
Boothbay Fund Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 9 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.